InRetail Peru Corp.
121,520.00
COP
0.00
(0.00%)
ISIN
PAL1801171A1
Return %
Stock
S&P 500
1Y
20.56
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Juan Carlos Vallejo Blanco
- Full Time Employees
- 50,571
- Sector
- Retail trade
- Industry
- Food retail
- Address
- Calle Morelli 139, Piso 5, San Borja Panama City Panama 15036
- IPO Date
- Oct 3, 2012
- Website
- inretail.pe
- Similar Companies
- Business
- InRetail Perú Corp. (INREF) operates as a leading multi-format retailer primarily in Peru, with a nationwide presence across food retail, pharmacies, shopping malls, distribution, and digital segments. The company offers supermarkets and hypermarkets under the Plaza Vea Hiper, Plaza Vea Super, Vivanda, Makro, and Mass brands; pharmacies under the Inkafarma and Mifarma brands; shopping centers under the Real Plaza brand; pharmaceutical distribution services; real estate development and space leasing; and digital retail platforms, serving diverse socioeconomic segments with everyday-low pricing, wellness products, cash-and-carry wholesale, and entertainment hubs. InRetail Perú Corp., a subsidiary of Intercorp Retail Inc. and part of Peru's Intercorp Group, was incorporated in 2011 and maintains headquarters at Calle Morelli 139 in Lima, Peru, employing approximately 47,000 people with operations spanning 24 cities in the country. Recent developments include robust food retail expansion with approximately 350 new Mass discount stores opened in 2024 and plans for 300 more plus two additional Makro outlets in 2025; entry into the Chilean market via the October 2024 acquisition of Supermercados Erbi's 33 hard-discount stores to test regional growth strategies; inauguration of 69 net Mass stores and 19 new pharmacies in Q2 2025 amid 9% food retail and 5.3% pharmacy revenue growth; and ongoing share repurchases of about 700,000 shares using pharmacy cash flows.